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We presentacase of successful magnetic resonance imaging-guided focused ultrasoundsurgery(MRgFUS)of auterineﬁbroidin a
patient with extensive anterior abdominal wall surgical scars from two longitudinal laparotomies, a total colectomy and ileostomy.
This case demonstrates that MRgFUS can be safely used in patients with an ostomy and signiﬁcant abdominal wall scarring, but
careful pretreatment planning and positioning during treatment is needed.
1.CaseReport
MRI-guided focused ultrasound (MRgFUS) is a noninvasive
method of thermal ablation, which, through MRI guidance,
allows for 3D treatment planning and feedback of tempera-
ture deposition in the area to be treated. MRgFUS was FDA
approved for ﬁbroid treatments in 2004 [1, 2]. Obstruction
in the near-ﬁeld of the focused ultrasound beam, such as
from an ostomy bag, or indeed extensive abdominal wall
scar tissue (which has diﬀerent acoustic properties), could
lead to increased absorption of acoustic energy and skin
burns [3]. We discuss MRgFUS of a symptomatic uterine
ﬁbroid in a patient with longitudinal abdominal scarring
and ileostomy and discuss how we circumnavigated these
potential obstructions.
A nulliparous 48-year-old premenopausal woman with
a symptomatic uterine ﬁbroid presented for MRgFUS. She
had menometrorrhagia, bulk symptoms, urinary frequency,
and fatigue. Her ﬁbroid symptom severity score and health-
related quality of life questionnaire (transformed UFS-SSS
QOL) [4–7] was 93.8 (on a scale of 0–100), indicating very
symptomatic disease. She had declined hysterectomy, having
already had two laparotomies in the past for total colectomy
and ileoanal pouch formation for inﬂammatory bowel
disease, and subsequent lysis of adhesions and ileostomy. She
was fearful of possible complications related to adhesions
and pelvic ﬂoor compromise should she undergo additional
surgery.Inaddition,asaself-employedwoman,shewasmost
interested in a minimally invasive intervention requiring the
least amount of recovery time.
On physical examination, there was a right lower quad-
rant ileostomy and a well-healed vertical scar extending from
above the umbilicus to the mons pubis. A ﬁrm, nontender
pelvis mass in the left lower quadrant was appreciated up
to the level of the umbilicus. Diagnostic MRI demonstrated
the uterus measuring 9.7 × 10.0 × 9.5cm with a single
anterior intramural ﬁbroid measuring 8.8 × 7.6 × 6.4cm.
The ﬁbroid was homogenous and isointense to muscle on
the T1-weighted images and of low signal intensity on the
T2-weightedimagesanddemonstratedmostlyhomogeneous
enhancement post intravenous gadolinium injection.
After review of the screening MR images (Figures 1(a)
and 1(b)) and consultation with the hospital ostomy service,
a plan was made to attach the ostomy bag oﬀ-center, cut
back the wafer/base plate, and rotate the bag oﬀ to the side
such that it lay away from the center of the abdomen. The2 ISRN Obstetrics and Gynecology
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Figure 1: Pretreatment screening axial T2 weighted screening MR images (a, b) and axial T2 weighted images on the day of treatment (c,
d). On screening images, the ostomy is evident in the right lower quadrant (grey arrows), and longitudinal abdominal scarring is seen in
the subcutaneous tissue in the midline (black arrows) which overlies the uterine ﬁbroid (F). The ostomy bag can also be seen to overlie the
anterior abdominal wall (white thick arrows). On the day of treatment, the ostomy bag was placed oﬀ to the side and was no longer visible
on the images. The skin of the anterior abdominal wall was pulled oﬀ to the right side such that the ostomy and scar are now out of the
treatment window and the ﬁbroid (F) is accessible for treatment.
patient was asked to fast from midnight the night before and
to maintain a liquid diet in the 24 hours prior to treatment
to decrease ostomy output.
On the day of the procedure, the patient was positioned
prone and slightly oﬀ-center on the MRI table, such that the
left lower anterior wall was positioned over the gel pad and
theostomyoﬀtotherightsideandoutofthetreatmentpath.
The skin of the anterior abdominal wall was pulled towards
theostomy,suchthatthemidlinelongitudinalscarswerealso
out of the treatment ﬁeld, increasing the size of the acoustic
or treatment window and subsequently allowing treatment
of a greater ﬁbroid volume (Figures 1(c) and 1(d)).
During treatment, as always, careful attention was paid
to the thermal maps to ensure no heat builds up outside
of the ﬁbroid. Following delivery of multiple high power
sonications to the treatment area, intravenous gadolinium
was administrated and showed a 4.1 × 5 × 4.7cm area
of nonenhancement, consistent with necrosis, within the
ﬁbroid. No abnormal areas of enhancement within the
subcutaneous tissue or the regions of the scar were identiﬁed
(Figures 2(a)–2(d)).
Three months post treatment, the patient reported
marked symptom improvement with a decrease in bulk
symptoms and increase in energy. Her transformed UFS-SSS
QOL decreased from 93.8 to 50. No skin changes, abnormal-
ity, or any changes in ostomy function were reported.
2. Discussion
To our knowledge, this case report is the ﬁrst to describe
MRgFUS in a patient with an ostomy and a history of
multiple abdominal surgeries. This case posed a number of
potential challenges: the presence of an ostomy, longitudinal
abdominalscarringandmultipleabdominalsurgeries,which
pose a threat of underlying adhesions. MRgFUS treatment
of patients with horizontal scars [8], usually secondary to
cesarean sections or myomectomies [8], can be managed
by angling the ultrasound beam superior or inferior to the
horizontal Pfannenstiel scar. However, longitudinal scars are
more problematic as they are usually midline and the beam
has to penetrate from either side of a usually extensive
scar.ISRN Obstetrics and Gynecology 3
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Figure 2: T1 spoiled gradient recalled (SPGR) echo sequences in the axial (a, c) and sagittal (b, d) planes, post administration of intravenous
gadolinium gadopentate. Imaging acquired pretreatment (a, b) demonstrates homogenous enhancement of the ﬁbroid (F), and post
treatment (c, d) there is a large area of nonenhancement within the ﬁbroid (outlined in white), consistent with a treatment eﬀect. There
is no evidence for enhancement in the scar tissues of the anterior abdominal wall. (P): Pubic bone; (S): spine.
This case demonstrates how thorough individualized,
patient-speciﬁc planning is paramount to a successful treat-
ment. The presence of an overlying ostomy bag and stoma,
coupledwithlongitudinalscars,arenotacontraindicationto
successful MRgFUS ﬁbroid treatment, which is a treatment
option to be considered by patients with such medical
problems.
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